DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Derangere V. et al.
Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?.
Oncotarget 2016;
7: 9309-9321
We do not assume any responsibility for the contents of the web pages of other providers.